Navigation Links
DNA Engine Tetrad 2 Peltier Thermal Cycler from Bio-Rad

ProductsDNA Engine Tetrad 2 Peltier Thermal Cycler from Bio-Rad
Company Bio-Rad
Item DNA Engine Tetrad 2 Peltier Thermal Cycler
Price 
Description The Tetrad 2 thermal cycler is a completely redesigned and updated version of the original Tetrad chassis, and it accepts the full line of well-proven Alpha heat-pump assemblies. It delivers the same precision in thermal performance as the DNA Engine Dyad, and original Tetrad thermal cyclers, allowing easy transport of protocols among platforms.

The Tetrad 2 contains an onboard Pentium-class computer that delivers an advanced graphical interfaceideal for managing production-grade thermal cycling. For those labs that value quick training, the creation and editing of protocols can be accomplished rapidly and easily via the mouse-directed point-and-click navigation. Real-time displays of block, sample and lid temperatures provide quality assurance that the thermal cycler is performing as directed. Superior software features, such as error tracking logs, run tracking files, problem resolution trees and file management tools, offer invaluable information for troubleshooting during high throughput runs.

Info Bio-RadBio-Rad
Bio-Rad Laboratories, Inc.
Life Science Research Group
2000 Alfred Nobel Drive
Hercules, CA 94547
USA
Customer Service: 800-424 6723
Fax Number: 800-879 2289
Web Site: http://discover.bio-rad.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. DNA Engine Opticon Continuous Fluorescence Detection System from Bio-Rad
2. DNA Engine Opticon Real-Time PCR Detection System from Bio-Rad
3. DNA Engine Thermal Cycler Chassis w/384-well block & motorized lid from Bio-Rad
4. DNA Engine Thermal Cycler Chassis, w/384-well block from Bio-Rad
5. DNA Engine Dyad Thermal Cycler Chassis from Bio-Rad
6. DNA Engine Tetrad 2 Thermal Cycler Chassis from Bio-Rad
7. DNA Engine Tetrad 2 Peltier Thermal Cycler, w/4 x 384-well blocks from Bio-Rad
8. DNA Engine Tetrad 2 Peltier Thermal Cycler from Bio-Rad
9. DNA Engine Dyad Thermal Cycler Chassis, w/2 x 384-well blocks from Bio-Rad
10. DNA Engine Tetrad 2 Peltier Thermal Cycler, w/4 x 384-well blocks & motorized lid from Bio-Rad
11. DNA Engine Opticon 2 Continuous Fluorescence Detection System from Bio-Rad
GIBCO Streptomycin Sulfate from Invitrogen
GIBCO Dulbeccos Modified Eagle Medium (D-MEM) (1X); powder (low glucose) from Invitrogen
Goat Anti-Adducin beta (C-16) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Rat TNF-alpha ELISA Kit, OptEIA from BD Biosciences Pharmingen
Biology Products:
(Date:11/4/2009)...4 GenVault Corporation (Carlsbad, ...., has joined its Board of Directors. Dr. Brody, ...stitute, is an acclaimed physician-scientist and u...tute, Dr. Brody served as president of The Johns H... Academy of Engineering and the Institute of Medic...
(Date:11/3/2009)...ultimate loner of the ocean, cruising thousands of...rs has discovered that the sharks have maintained ...ens of thousands of years the white sharks in the ...es into a population genetically distinct from sha...a large, highly mobile species," said Salvador Jor...
(Date:11/3/2009)...Ind. - Chief executives in 35 of the top Fortune 5...r "ideal salaries" in 2008, according to a new typ...versity researcher to determine fair CEO compensat...rporate governance issues of the day is how to det...nkatasubramanian, a professor of chemical engineer...
Breaking Biology News(10 mins):Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 2Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 3Tags reveal white sharks have neighborhoods in the north Pacific, say Stanford researchers 2Tags reveal white sharks have neighborhoods in the north Pacific, say Stanford researchers 3Tags reveal white sharks have neighborhoods in the north Pacific, say Stanford researchers 4New theory on fairness in economics targets CEO pay 2New theory on fairness in economics targets CEO pay 3New theory on fairness in economics targets CEO pay 4Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 13447 1Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 13447 2Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 13447 3Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 13447 4Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 13447 5Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 13447 6Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 13447 7NeurogesX Reports Second Quarter 2009 Results 13446 1NeurogesX Reports Second Quarter 2009 Results 13446 2NeurogesX Reports Second Quarter 2009 Results 13446 3NeurogesX Reports Second Quarter 2009 Results 13446 4NeurogesX Reports Second Quarter 2009 Results 13446 5NeurogesX Reports Second Quarter 2009 Results 13446 6NeurogesX Reports Second Quarter 2009 Results 13446 7NeurogesX Reports Second Quarter 2009 Results 13446 8NeurogesX Reports Second Quarter 2009 Results 13446 9NeurogesX Reports Second Quarter 2009 Results 13446 10NeurogesX Reports Second Quarter 2009 Results 13446 11NeurogesX Reports Second Quarter 2009 Results 13446 12Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 1Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 2Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 3Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 4Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 5Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 6Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 7Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 8Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 9Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 10Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 11Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 12Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 13Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 14Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 15Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 16Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 17Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 18
... Cancer Research at the University of California, ...rkable property of the contractile ring, a structu...the contractile ring works to divide the cell may ...ontrolled cell division in cancer. , The researc...he length of the contractile ring are reduced duri...
...iety (ACerS) announced today that it is launching ...edicated to glass research: The International Jou...enerations of glass and glass-related materials ar... many of the world,s emerging technologies, includ... environmental, optical and defense technologies s...
.... , In the context of the climatic change of th... global warming are of great interest. That is the...pension of solid or liquid particles on a gaseous ...cooling of the atmosphere. , Juan Luis Guerrero ...nique for atmospheric characterization by elastic ...
Other Biology News:Study may aid efforts to prevent uncontrolled cell division in cancer 2New journal on advanced glass research to debut 2A research work will be the reference to characterize the climatic impact of desert dust 2
(Date:11/5/2009)... Brooke Sanders brings a new look to Pro R... November 5, 2009 -- Professional Reprographics, O... company is pleased to present Brooke Sanders to t...hics/PR specialist. The addition of Brooke to the ... within Professional Reprographics., , ,Brooke bri...
(Date:11/4/2009)... The Human Anthrax Vaccine Program must be...the feature film "A Call to Arms:2009 Edition...ot;Fatal Immunity: The Human Anthrax Vaccine Story...esent danger of top secret government science turn...accountability to its victims. It is available fo...
(Date:11/4/2009)... Va., Nov. 4 Star Scie...at the company plans to introduce the CigRx(TM) nu...ock Creek Pharmaceuticals, for worldwide marketing...Inc . (Nasdaq: VTIV). inVentiv Health offers a c...very stage of the product lifecycle, in a range of...
(Date:11/4/2009)... Calif., Nov. 4 Onyx Pha...d that it will present at the Credit Suisse 18th A... 11, at 9:30 a.m. Mountain Time (8:30 a.m. Pacific...ast of the presentation on our website at: http:...,, It is recommended that listeners log on 15 m...
Breaking Biology Technology:Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 2Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 3Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 4Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 5Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 6Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 7Star Scientific Plans Worldwide Marketing and Sales of CigRx(TM) Nutraceutical in Partnership with inVentiv Health 2Star Scientific Plans Worldwide Marketing and Sales of CigRx(TM) Nutraceutical in Partnership with inVentiv Health 3Star Scientific Plans Worldwide Marketing and Sales of CigRx(TM) Nutraceutical in Partnership with inVentiv Health 4